Fit and healthy father diagnosed with stage 4 bowel cancer reveals first warning sign
Geoffrey Seymour discovered blood in his stool just before his 41st birthday, which turned out to be stage four cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A formerly fit and healthy father diagnosed with stage four cancer has shared an update as he continues to seek treatment for his condition.
Geoffrey Seymour, 41, revealed last year how he was left looking like the “Nightmare on Elm Street” after a horrific reaction to chemotherapy left him too embarrassed to go to his young son’s cricket matches. He is now hoping to save his life with a ground-breaking vaccine.
Geoffrey, a procurement specialist, loved playing tennis, basketball and cricket and had always been healthy until just before his 41st birthday when he began experiencing blood in his stool.
He was aware of this being a symptom for cancer from adverts on the television, so quickly went to his GP.
Geoffrey, who lives in Richmond, London, with his wife Santa, 44, and their son Marco, 10, was diagnosed with stage four colorectal cancer, which had spread from his colon to his liver – a situation so severe and seemingly hopeless he likened it to “being wrapped in a paper bag that is on fire”.
He also had a bad reaction to chemotherapy severely blistering the skin on his face and, according to Geoffrey, making him look like Freddy Krueger from the 1984 horror film, Nightmare on Elm Street.
The chemotherapy stopped working however, and in an attempt to save his life, Geoffrey travelled to Germany for dendritic cell therapy – where a personalised vaccine is created in a lab with the aim of stimulating the immune system.
Research in this area is at an early stage, according to Cancer Research UK, and so the treatment was not cheap – just one injection in Germany, on October 17, cost £17,000 and Geoffrey is now waiting to see if it was enough to help him, while continuing to fundraise to pay for it.
He said: “I couldn’t even wait until the end of the fundraising to have it done just because I’m so worried that the disease was going to spread.”
Geoffrey was determined to find a new approach after three sessions of five doses of chemotherapy didn’t work and left him with side-effects so bad he no longer wanted to go out in public, even to see his little boy play cricket
“I had a really bad reaction in my face, it was full of painful blistering that made my face feel like it was on fire,” he said.
“I just got to the point where I was looking a bit like Nightmare on Elm Street. Unless I went there with a bag on my head, I’d have other people coming up to me and looking at me thinking, ‘What’s wrong with this guy?’ when I’m quite happy blending into the crowd.”
Geoffrey’s ordeal began in April 2021, just two weeks before his 41st birthday on March 4, when he got the first warning signals of cancer.
After spotting blood in his stool, Geoffrey decided to visit his GP, as he knew it could be a symptom of cancer. And in late March at Kingston Hospital, he was diagnosed with stage four colorectal cancer, which had metastasized in the liver.
After the diagnosis, in March 2021, he had five cycles of chemotherapy every three weeks which initially reduced the lesions in his liver. At this point he says he felt “optimistic”.
In December 2021, he had surgery to have a third of his liver removed, and the medical team began getting him ready for radiotherapy which was going to be used on his colon – he even had radio markers tattooed for the laser alignment.
A month later, a scan showed more tumours in his liver, so he had another round of chemotherapy. This time it was a success and liver surgery was booked in for June 2022.
But, just as things were looking up, a few weeks before the surgery, a scan revealed disease progression. Geoffrey was put back on chemotherapy with a different agent and the surgery was cancelled.
After just two cycles, blood work and a scan showed disease progression again, all while the side effects were getting unbearable for Geoffrey.
He said: “The side effects have gotten worse, worse, worse, and now, chemotherapy is just not effective anymore, the body’s gotten used to it.”
Explaining why he reacted badly to a chemotherapy drug, he said: “Essentially it kills all your fast-growing cells, which include your cancer cells, but also includes your hair and nails. I had a really bad reaction to that in my face.”
Determined to find an alternative, Geoffrey started doing his own research by looking online and found dendritic cell therapy, only to be told it would not be available to him in the UK.
He decided to fly to a laboratory in Ulm, Germany to have the week-long treatment on October 17 2022. Friends and family rallied round to contribute towards his Go Fund Me appeal, which has raised over £14,000 and helped to pay for the £17,000 injection.
“I am still in pain, I have a lot of pain, which I’m trying to find a good balance of very strong medications,” he said in November.
On 6 March 2023, Geoffrey shared an update to his fundraising page.
“Today I am trying hard to catch up and get back to a good place after what has surely been, a challenging time,” he wrote.
“Every movement has become an effort as I continue my road to health and recovery. I last wrote going for a sigmoidoscopy to confirm what the actual issues were, unfortunately the issues were obstruction due to my colon being inflamed from the primary tumour.
“This meant I had to be transferred to st Marks A&E to have a stoma bag attached. I was promised instant relief and I got instant relief from the blockage but it was temporary relief as after being discharged I found myself back in a&e not feeling great. After a few days of time wasting in Kingston I went home but with the knowledge that in actuality the recovery from having a stoma bag is a long and arduous journey filled with constant adjustments to energy and diet.
He continued: “So that’s where I am, it’s a good thing as I get to focus on getting stronger so that I am in a good place for when I go to Germany for my 3rd dose of TACE. I hope wth every part of my being that these delays have not derailed the good work done with the liver but the reality is that the colon and liver need solutions and treatment at the same time. At usual my wife is an angel and the support I have at home keeps me strong. Look after yourselves everyone. Catch you soon.”
Specialist cancer information nurse at Cancer Research UK Caroline Geraghty said: “Dendritic cell therapy is a type of vaccine that can treat cancer. Dendritic cells help immune system recognise and attack abnormal cells, such as cancer cells.
“To make the vaccine, scientists grow dendritic cells alongside cancer cells in the lab. The vaccine then stimulates your immune system to attack the cancer. It’s still being researched, so the evidence base is not yet strong enough for it to be available in the UK.
“Decisions about the best course of treatment must be based on sound evidence of benefit – so it’s important patients talk to their doctor about any alternative treatment they might be considering.”
She added: “Thanks to ongoing developments in research, there continues to be many new cancer drugs showing effectiveness in clinical trials, providing potential options for people with cancer.
“But while regulators have improved the speed at which they assess these for routine NHS use, there are still, unfortunately, times when particular drugs aren’t yet easily accessible for people who may benefit. We understand how frustrating this can be.”